SYRUP weakens as selling pressure dominates the short-term outlook

SYRUP weakens as selling pressure dominates the short-term outlook
Maple drops 7.92% today to $0.0954

Maple (SYRUP) is trading at $0.0954, marking a daily decline of 7.92%. The price sits below its key moving averages, reflecting pronounced downward momentum in today's session.

SYRUP price prediction
24H -14.75%
$0.0815
48H -17.57%
$0.0788
7D -21.03%
$0.0755
1M -81.49%
$0.0177
3M -47.8%
$0.0499
6M -65.48%
$0.033
12M 26.78%
$0.1212
Current price: $0.0956 -0.0076 7.36%
Real-time Data 14:09
Daily range 0.0945 Arrow from to Icon 0.1029
Weekly range 0.0907 Arrow from to Icon 0.1142
Loading...

Highlights

  • Maple closed the third quarter with $4.73 billion in assets under management, up 2.5% from the previous quarter.
  • Institutional participation increased, as total value locked on Maple Institutional climbed 15.5% to $870 million.
  • SYRUP/USD is experiencing sustained bearish pressure with strong sell signals from most indicators and an expected range of $0.0792 to $0.1007 in the next few days.

Asset base expansion and institutional traction amid broader selling

Maple ended the third quarter with $4.73 billion in assets under management, reflecting a 2.5% increase from the preceding quarter and indicating an expansion in investor assets. Institutional demand was further evidenced by a 15.5% rise in total value locked on Maple Institutional, reaching $870 million, which highlights growing participation from larger market players. The syrupUSDG product achieved $375 million in scale during its first quarter, according to Tokenpost, underscoring successful new product rollouts, though price action has remained under broader selling pressure.

Maple Finance asset chart
Maple Finance price dynamics. Source: TradingView.

Bearish technical bias with momentum indicators mixed and oversold

The SYRUP/USD pair is trading below the H1 SMA-20 at $0.0978 and the H1 SMA-50 at $0.0977, while also remaining well below the D1 SMA-200 at $0.1808. The Ichimoku Kijun at $0.0995 serves as immediate resistance. Momentum indicators present conflicting signals: MACD signals a Sell, whereas ADX shows a Buy. RSI remains in the neutral zone, though both Stoch RSI and CCI are deep in the oversold region, hinting at selling exhaustion. Bull/Bear Power is negative, confirming short-term seller dominance, and the Awesome Oscillator gives a Strong Sell reading, emphasizing a prevailing bearish bias.

Low breakout probability as downside risk persists near key support

Over the next two to three trading days, SYRUP/USD is expected to fluctuate within the $0.0792 to $0.1007 range, a volatility band relative to current levels. The probability of a sustained upward move is very low, while further downside is likely if support near $0.0792 breaks. The baseline scenario anticipates stabilization within the current corridor; a convincing push above $0.0995 may open the way to higher resistance levels, while selling momentum below $0.0792 would increase the risk of an accelerated decline.

Anton Kharitonov, Traders Union expert, notes that despite Maple's progress in institutional adoption and asset growth, technical conditions remain notably bearish. Price is still below key levels such as the H1 SMA-20 at $0.0978, alongside persistent sell signals from several momentum indicators. He sees little evidence of a sustainable recovery unless $0.0995 is reclaimed. "Until buyers decisively retake resistance, my outlook for SYRUP stays defensive, with risks skewed to the downside."

Previously it was reported that Maple (SYRUP) was exhibiting mixed short-term technical signals against a backdrop of longer-term resistance and waning investor participation. The latest data reinforces a bearish technical outlook, with persistent selling pressure heightening the importance of monitoring the $0.0792 support area as a critical downside risk in the coming days.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.